Shorts bent again today, another huge move

*together with Mode Mobile & InvestorPlace

Good day, 360!

Here are some of our top movers today. If you missed Jason’s explosive GROWTH CHAMBER training yesterday, we’ve go that here 🔥. Give it a shot… and be the best prepared trader on the Street!

FOCUS LIST🔎

ALUR - Up over 300% in the pre-market after announcing plans to optimize muscle mass during GLP-1 therapy In combination with the Allurion program 

TWLO - Up over 16% in pre after issuing profit forecast, preliminary Q4 results

RVYL - Up over 10% in pre after announcing ot has executed repurchase and repayment agreement with securityholder to retire all outstanding series B convertible preferred stock and outstanding balance of 8% senior convertible note

HOTLIST🔥

ALUR - Up over 300% in the pre-market after announcing plans to optimize muscle mass during GLP-1 therapy In combination with the Allurion program

Allurion Technologies Inc. (ALUR) focuses on ending obesity with a weight loss platform to treat people who are overweight.

In the after-hours yesterday, the company announced its intention to initiate a clinical study on the combination of the Allurion Program with GLP-1 agonists to improve muscle mass and overall body composition.

Previous studies in patients undergoing GLP-1 therapy have demonstrated reductions in lean mass of approximately 40% as a proportion of total weight lost.1 

In contrast, in previous studies, patients treated with the Allurion Balloon in combination with the Allurion Virtual Care Suite have demonstrated strong patient outcomes in which patients lose weight while maintaining, and in some cases, increasing, muscle mass.

 In one study of 571 patients, patients treated with the Allurion Balloon gained 5.6% in lean body mass while losing 14% of their total body weight over four months.

Shares of ALUR traded up over 300% in the pre-market in reaction to the news.

The first target for bulls is the pre-market high at $18.38. Beyond that, $17.50 and $20 come into play with $23 and $33 above that.

Below $18.38, targets to the downside are $12, $10, $8, $6 and then a gap fill at $3.70.

TWLO - Up over 16% in pre after issuing profit forecast, preliminary Q4 results 

Twilio Inc. (TWLO) together with its subsidiaries, provides customer engagement platform solutions in the United States and internationally. The company provides various application programming interfaces and software solutions for communications between customers and end users.

In the after-hours yesterday, the company stated it expects revenue growth for Q4 of about 11%. 

In a separate update at its investor day event, the company also unveiled its three-year framework. For 2025, the company is expecting free cash flow (FCF) in a range of $825M to $850M on 7% to 8% revenue growth year over year.

Looking further ahead to 2027, Twilio is targeting an adjusted operating margin increasing between 21% and 22%, above Visible Alpha’s 19.68% consensus.

The company also unveiled a $2 billion share buyback program.

Following the announcement, Morgan Stanley analysts lifted their price target on the stock to $144 from $118.

Shares of TWLO traded up over 16% in the pre-market in reaction to the news.

The first target for bulls is resistance at $134.50 with the pre-market high at $136.45 next. Beyond that $140, $145 and $150 come into play.

Below $134.50, targets to the downside are $130, $128, $126 and $124 , with $120 and $118 below that.

RVYL - Up over 10% in pre after announcing ot has executed repurchase and repayment agreement with securityholder to retire all outstanding series B convertible preferred stock and outstanding balance of 8% senior convertible note  

Ryvyl Inc. (RVYL) is a technology company, engages in the development, marketing, and sale of blockchain-based payment solutions in North America, Europe, and Asia.

In the pre-market this morning, the company announced that it has executed a Preferred Stock Repurchase and Note Repayment Agreement for the full repayment and termination of an 8% Senior Convertible Note and the redemption of all shares of the Company's Series B Convertible Preferred Stock

The Definitive Agreement provides for:

• A first tranche payment of $13.0 million for the redemption of all of the shares of Preferred Stock held by the Securityholder, and payment of a portion of the outstanding balance of the Note so that the remaining outstanding principal balance will be $4.0 million.

• Advancing the maturity date for the remaining balance of $4.0 million due under the Note, following payment of the first tranche, to April 30, 2025.

The Company is required to pay the first tranche payment of $13.0 million on or before January 27, 2025. The first tranche due date may be extended to February 3, 2025, at the sole option of the Company, in consideration for RYVYL’s payment of an additional $50,000.

• Prior to payment of the first tranche payment, the Securityholder shall retain the ability, subject to certain market limitations, to convert the Note and the Preferred Stock into common stock.

Shares of RVYL traded up over 10% in the pre-market in reaction to the news.

Targets to the upside are $1.65, $1.75 and then the pre-market high at $1.94. Beyond that, $2, $2.30, $2.40 and $2.60 come into play.

Below $1.65, targets to the downside are $1.50, a gap fill at $1.46 and then $1.36 and $1.28 below that.

MARKET NEWS 📰